1. Medtech Insight

Apple Drops Pulse Oximeter Features To Subvert Import Ban

But a court of appeals ruling has put the ban back in effect.

 
• By Hannah Daniel

After a short import ban, Apple is modifying its watches to remove the pulse oximetry technology that was ruled to violate several Masimo patents.

ONE TME USE: Apple Watch ECG App
• Source: Shutterstock

US Customs and Border Protection will allow Apple to import its Series 9 and Ultra 2 Watches with a software update to remove their pulse oximetry technology.

The Exclusion Order Enforcement Branch of CBP announced the ruling 12 January and said that the updated watches would fall outside of the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

More from Medtech Insight

Roche To Localize CGM Manufacturing in US with $550M Indiana Site Investment

 
• By Shubham Singh

Roche’s Indianapolis site currently produces 5.2 billion Accu-Chek test strips annually and supports distribution to 53 countries. The new CGM line will add to an already diversified operational footprint, which includes R&D, laboratories, manufacturing, and IT services.

What’s A Diagnostic? WHO Wants To Know

 
• By Elizabeth Orr

The World Health Organization is seeking input from stakeholders to create an official definition of the term ‘diagnostics.’ This initiative follows a 2023 resolution aimed at enhancing global diagnostics capacity; the definition, it is hoped, will help drive the creation of effective health policies. Comments will be accepted until 23 May.

‘Help Us Deregulate’: RFK Announces RFI For Trimming Government Health Agencies

 
• By Brian Bossetta

HHS Secretary Robert F. Kennedy, Jr. is asking the public to help cut waste across the government’s health agencies. Kennedy announced a 60-day comment period allowing the public to take part in a broader federal initiative to reduce regulations and increase transparency.